Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Tackling Rare Diseases
Tackling Rare Diseases
by conchita-marotz
in the United States. Paul Melmeyer. Associate. ...
Emerging and Re-emerging Diseases
Emerging and Re-emerging Diseases
by unita
Dr. . Urfi. ?. COVID-19. Zika. AIDS . Avian Influe...
6. Priority diseases and reasons for
6. Priority diseases and reasons for
by kaptainpositive
inclusion 1 6.19 Rare diseases See Background Pape...
Diseases of the respiratory system lecture 5
Diseases of the respiratory system lecture 5
by karlyn-bohler
Dr. . Heyam. . Awad. FRCPath. Restrictive lung...
Clinical Investigator Training Course
Clinical Investigator Training Course
by luanne-stotts
Issues in Clinical Trial Design for Rare Diseases...
BONE MARROW TARGETING AND TARGETING TO LYSOSOMAL DISEASES
BONE MARROW TARGETING AND TARGETING TO LYSOSOMAL DISEASES
by yoshiko-marsland
By. . SOMESHWAR.K. M.PHARM.. ...
Drug Residue Avoidance in Poultry
Drug Residue Avoidance in Poultry
by yvonne
Poultry Industry. The poultry industry is a dynami...
Schedule H and H1 Conditions of Sch. H1 drug:
Schedule H and H1 Conditions of Sch. H1 drug:
by isabella2
The Supply of a drug specified in Schedule H1 shal...
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by debby-jeon
in CNS disorders. Subbu. . Apparsundaram. , PhD....
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by tatyana-admore
in CNS disorders. Subbu. . Apparsundaram. , PhD....
Chapter Eleven
Chapter Eleven
by mitsue-stanley
Communicable Diseases. The Importance of Communic...
March 20th,
March 20th,
by lois-ondreau
2014. Potential elimination of the Orphan Drug ...
Biomarkers & Pharmacogenomics
Biomarkers & Pharmacogenomics
by conchita-marotz
in CNS disorders. Subbu. . Apparsundaram. , PhD....
CHI-California Healthcare Institute is a non-profit public policy rese
CHI-California Healthcare Institute is a non-profit public policy rese
by bigboybikers
biomedical R&D industry. CHI represents more than ...
Principles clinico -pharmaceutical
Principles clinico -pharmaceutical
by taylor
approach to the selection of. . drugs. for the tr...
Translational Research through Public-Private Partnerships
Translational Research through Public-Private Partnerships
by faustina-dinatale
65. th. Annual . Bohan. Lecture. Scott J. Weir...
The Small Ubiquitin-like Modifiers: Established and emergin
The Small Ubiquitin-like Modifiers: Established and emergin
by kittie-lecroy
diseases. Mike Tatham. Ron Hay lab. Wellcome Trus...
Medical textiles, Leeds:
Medical textiles, Leeds:
by liane-varnes
Things . that really matter. Dr. Parikshit Goswam...
Going Beyond the Current Regulatory and Incentives Framewor
Going Beyond the Current Regulatory and Incentives Framewor
by calandra-battersby
A new proposal to foster greater orphan drug deve...
The Drugs and Magic Remedies
The Drugs and Magic Remedies
by conchita-marotz
(Objectionable Advertisements). Act, 1954. INTROD...
Asia Pacific Academy of Ophthalmology
Asia Pacific Academy of Ophthalmology
by mitsue-stanley
(APAO). Eye Diseases Clinical Trials Summary. Xia...
GENERAL CHEMOTHERAPY
GENERAL CHEMOTHERAPY
by susan
General Consideration Part . VI. . …………...
mARIA FERRARA M.D SPECIALIST IN ADULT PSYCHIATRY
mARIA FERRARA M.D SPECIALIST IN ADULT PSYCHIATRY
by lucy
Department. Of . Mental. . Health. , Modena, . I...
March 2016 INFECTIOUS DISEASES
March 2016 INFECTIOUS DISEASES
by obrien
To identify of signs and symptoms of infectious di...
Diseases of Urinary System Part-1
Diseases of Urinary System Part-1
by margaret
Dr. . Pallav. Shekhar. Asstt. . Professor. Veteri...
MULTITARGET APPROACH Neurodegenerative Diseases
MULTITARGET APPROACH Neurodegenerative Diseases
by elena
:. . complex. . multifactorial. . syndromes. P...
More on Generic Drugs
More on Generic Drugs
by lindy-dunigan
Global Classrooms 2013. Rachel . Hunkler. Non-com...
Improving the process of rare disease treatment development
Improving the process of rare disease treatment development
by lindy-dunigan
“. EMERGING THERAPIES FOR RARE DISEASES. ”. ...
National Healthcare Technology Platform
National Healthcare Technology Platform
by olivia-moreira
Interoperability concern in healthcare. François...
The Budget Impact of Drugs Treating Rare Diseases in Canada
The Budget Impact of Drugs Treating Rare Diseases in Canada
by myesha-ticknor
: A 2007-2013 MIDAS Sales Data Analysis. April 14...
Michael Wong, MD Sr. Medical Director, Infectious Diseases
Michael Wong, MD Sr. Medical Director, Infectious Diseases
by test
Sarepta. Therapeutics. Associate Professor of Me...
Gene and Antisense Therapy
Gene and Antisense Therapy
by ellena-manuel
William Brooks. Medicinal Chemistry. March 31, 20...
Exaptation and innovation
Exaptation and innovation
by faustina-dinatale
Pierpaolo Andriani. Kedge Business School, France...
Chapter 42
Chapter 42
by luanne-stotts
Antifungal and Antiviral Drugs. Fungal Infections...
Medical Management
Medical Management
by conchita-marotz
of Pulmonary Hypertension. Dr. Christopher J Aren...
Pre-Exposure Prophylaxis (
Pre-Exposure Prophylaxis (
by ellena-manuel
PrEP. ) . Initiative:. Open Label Extension. Robe...
Potent and Selective inhibitors of histone
Potent and Selective inhibitors of histone
by olivia-moreira
deacetylase. 6 (HDAC6). small . molecule inhibit...
Extensively Drug-Resistant Tuberculosis,TaiwanTo the Editor: In Taiwan
Extensively Drug-Resistant Tuberculosis,TaiwanTo the Editor: In Taiwan
by myesha-ticknor
LETTERS LETTERS 850 Emerging Infectious Diseases
Potent and Selective inhibitors of histone
Potent and Selective inhibitors of histone
by calandra-battersby
deacetylase. 6 (HDAC6). small . molecule inhibit...
Dietary Therapy
Dietary Therapy
by myesha-ticknor
and Medicinal Therapy. Herbs are used traditional...